首页> 美国卫生研究院文献>Molecules >Three-Dimensional Biologically Relevant Spectrum (BRS-3D): Shape Similarity Profile Based on PDB Ligands as Molecular Descriptors
【2h】

Three-Dimensional Biologically Relevant Spectrum (BRS-3D): Shape Similarity Profile Based on PDB Ligands as Molecular Descriptors

机译:三维生物相关光谱(BRS-3D):基于PDB配体作为分子描述符的形状相似性谱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The crystallized ligands in the Protein Data Bank (PDB) can be treated as the inverse shapes of the active sites of corresponding proteins. Therefore, the shape similarity between a molecule and PDB ligands indicated the possibility of the molecule to bind with the targets. In this paper, we proposed a shape similarity profile that can be used as a molecular descriptor for ligand-based virtual screening. First, through three-dimensional (3D) structural clustering, 300 diverse ligands were extracted from the druggable protein–ligand database, sc-PDB. Then, each of the molecules under scrutiny was flexibly superimposed onto the 300 ligands. Superimpositions were scored by shape overlap and property similarity, producing a 300 dimensional similarity array termed the “Three-Dimensional Biologically Relevant Spectrum (BRS-3D)”. Finally, quantitative or discriminant models were developed with the 300 dimensional descriptor using machine learning methods (support vector machine). The effectiveness of this approach was evaluated using 42 benchmark data sets from the G protein-coupled receptor (GPCR) ligand library and the GPCR decoy database (GLL/GDD). We compared the performance of BRS-3D with other 2D and 3D state-of-the-art molecular descriptors. The results showed that models built with BRS-3D performed best for most GLL/GDD data sets. We also applied BRS-3D in histone deacetylase 1 inhibitors screening and GPCR subtype selectivity prediction. The advantages and disadvantages of this approach are discussed.
机译:可以将蛋白质数据库(PDB)中的结晶配体视为相应蛋白质活性位点的倒置形状。因此,分子与PDB配体之间的形状相似性表明该分子与靶标结合的可能性。在本文中,我们提出了一种形状相似性谱,可以用作基于配体的虚拟筛选的分子描述符。首先,通过三维(3D)结构聚类,从可药物化的蛋白质-配体数据库sc-PDB中提取了300种不同的配体。然后,将每个受检查的分子灵活地叠加在300个配体上。通过形状重叠和性质相似性对重叠进行评分,产生一个300维相似性阵列,称为“三维生物相关光谱(BRS-3D)”。最后,使用机器学习方法(支持向量机)使用300维描述符建立定量或判别模型。使用来自G蛋白偶联受体(GPCR)配体库和GPCR诱饵数据库(GLL / GDD)的42个基准数据集评估了该方法的有效性。我们将BRS-3D的性能与其他2D和3D最新的分子描述符进行了比较。结果表明,使用BRS-3D构建的模型对于大多数GLL / GDD数据集表现最佳。我们还将BRS-3D应用于组蛋白脱乙酰基酶1抑制剂筛选和GPCR亚型选择性预测。讨论了这种方法的优缺点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号